# EDGAR Filing Document

**Accession Number:** 0001411685
**File Stem:** 0001437749-23-007070
**Filing Date:** 2023-3
**Character Count:** 2358
**Document Hash:** 10d8faede27f5b3b90d6ada40e9b4d1c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-23-007070.hdr.sgml**: 20230418

**ACCESSION NUMBER**: 0001437749-23-007070

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230317

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vistagen Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001411685
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 205093315
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 343 ALLERTON AVENUE
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** 650-577-3600

**MAIL ADDRESS:**
- **STREET 1:** 343 ALLERTON AVENUE
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VistaGen Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20110610

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Excaliber Enterprises, Ltd.
- **DATE OF NAME CHANGE:** 20070906

![logo01.jpg](logo01.jpg)

March 17, 2023

<u>VIA EDGAR</u>

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tyler Howes

---

| | |
|:---|:---|
| **RE:** | **Vistagen Therapeutics, Inc.** |
|  | **Registration Statement on Form S-3** |
|  | **(File No. 333-270232)** |

---

Dear Mr. Howes,

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, Vistagen Therapeutics, Inc., a Nevada corporation (the "*Registrant*"), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 4:00 p.m. Eastern Standard Time on Tuesday, March 21, 2023, or as soon as practicable thereafter.

Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Mr. Daniel Rumsey at (619) 272-7062, to confirm the exact time at which the Registration Statement was declared effective.

---

| |
|:---|
| Very truly yours, |
| VISTAGEN THERAPEUTICS, INC. |
| <u>/s/ Shawn K. Singh</u> |
| Shawn K. Singh |
| Chief Executive Officer |

---

cc: Daniel W. Rumsey

Disclosure Law Group, a Professional Corporation